Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Financial advice can be crucial for young adults facing various financial challenges. Discover the benefits of seeking expert guidance.
25,237 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...
BlinkEx rolls out early-access trading focused on robust infrastructure—fast matching, strong risk controls, and reli...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
The Roundhill COSW ETF remains focused on generating weekly income by selling calls on COST, a structure that caps ga...
A Florida magistrate recommends dismissing the Zea antitrust lawsuit against the NAR and MLSs, warning the complaint ...
On a downbeat tech day, software stocks proved resilient as cloud demand and subscription revenue buoyed leaders like...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
ARTY leads humanoid-robot ETFs in 2026, outpacing BOTT and ROBO as investors chase AI software momentum. This shift h...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...